NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$5.74
0.15 (2.68%)
▲
5d:
-8.16%
30d:
-26.32%
90d:
-25.16%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
22d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NSRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NSRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $5.74, which is considered oversold relative to its 30-day fair value range of $6.13 to $7.74.
Technical Outlook: Technically, NSRX is in a downtrend. Immediate support is located at $5.50, while resistance sits at $7.20.
Market Sentiment: NSRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NSRX is in a downtrend. Immediate support is located at $5.50, while resistance sits at $7.20.
Market Sentiment: NSRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.13 -
$7.74
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- CAUTION: 5-day price weakness (-8.2%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$6.13 -
$7.74
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.50
Resistance Level
$7.20
Current Trend
Downtrend
Fundamental Context
Last updated: February 02, 2026 6:25 AM ET
Data refreshes hourly during market hours. Next update: 7:25 AM
Data refreshes hourly during market hours. Next update: 7:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1146 | 60 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$139 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$333 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$245 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$193 | 58 HOLD |